| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |